ANDREW J. PERLMAN

Insider Reports History

Location
Stanford, CA
Signature
/s/ Carolyn Tang, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ANDREW J. PERLMAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arcus Biosciences, Inc. Director Common Stock 42,625 $346,115 $8.12 10 Jun 2025 Direct
Arcus Biosciences, Inc. Director Stock Option (Right to Buy) 38,300 10 Jun 2025 Direct

Insider Reports Filed by ANDREW J. PERLMAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RCUS Arcus Biosciences, Inc. 10 Jun 2025 2 $0 4 Director 12 Jun 2025, 16:29
RCUS Arcus Biosciences, Inc. 06 Jun 2024 2 $0 4 Director 07 Jun 2024, 18:20
RCUS Arcus Biosciences, Inc. 15 Jun 2023 2 $0 4 Director 16 Jun 2023, 20:09
RCUS Arcus Biosciences, Inc. 14 Jun 2022 2 $0 4 Director 16 Jun 2022, 16:34
RCUS Arcus Biosciences, Inc. 03 Jun 2021 2 $0 4 Director 07 Jun 2021, 16:42